![Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19 | Neurology Clinical Practice Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19 | Neurology Clinical Practice](https://cp.neurology.org/sites/default/files/highwire/neurclinpract/12/4/e66/embed/inline-graphic-1.gif)
Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19 | Neurology Clinical Practice
Lysozyme-Decorated Gold and Molybdenum Bimetallic Nanoclusters for the Selective Detection of Bilirubin as a Jaundice Biomarker | ACS Applied Nano Materials
![Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env | Science Translational Medicine Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env | Science Translational Medicine](https://www.science.org/cms/asset/66b55791-b9de-4cec-ba09-0a963b668cbe/keyimage.gif)
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env | Science Translational Medicine
![Ancestral Peruvian ethnic fermented beverage “Chicha” based on purple corn (Zea mays L.): unraveling the health-relevant functional benefits | Journal of Ethnic Foods | Full Text Ancestral Peruvian ethnic fermented beverage “Chicha” based on purple corn (Zea mays L.): unraveling the health-relevant functional benefits | Journal of Ethnic Foods | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42779-020-00063-3/MediaObjects/42779_2020_63_Fig4_HTML.png)
Ancestral Peruvian ethnic fermented beverage “Chicha” based on purple corn (Zea mays L.): unraveling the health-relevant functional benefits | Journal of Ethnic Foods | Full Text
![PDF) A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults PDF) A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults](https://i1.rgstatic.net/publication/276459364_A_Phase_I_Double_Blind_Placebo-Controlled_Randomized_Study_of_the_Safety_and_Immunogenicity_of_an_Adjuvanted_HIV-1_Gag-Pol-Nef_Fusion_Protein_and_Adenovirus_35_Gag-RT-Int-Nef_Vaccine_in_Healthy_HIV-Un/links/56de788608aeb8b66f94b6f7/largepreview.png)
PDF) A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
![Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial - The Lancet HIV Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial - The Lancet HIV](https://www.thelancet.com/cms/attachment/707d5c59-0d7b-45e0-a5ff-e016c284339b/gr1_lrg.gif)
Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial - The Lancet HIV
![HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees | Journal of Virology HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees | Journal of Virology](https://journals.asm.org/cms/asset/3929342f-cd50-4b3a-8e3d-5b2c9df0e66e/jvi.2018.92.issue-8.largecover.jpg)
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees | Journal of Virology
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events
![Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env | Science Translational Medicine Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abk1533/asset/e80e8c99-3e64-48f2-b6bf-05c4eabed775/assets/images/large/scitranslmed.abk1533-f1.jpg)